Impax to Present at the UBS Global Life Sciences Conference

September 16, 2009
HAYWARD, Calif., Sep 16, 2009 (BUSINESS WIRE) -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Life Sciences Conference on Monday, September 21st, at 9:00 a.m. Eastern time. The conference will be held at The Grand Hyatt Hotel, New York City.

Individuals may listen to the live or an archived presentation made at the conferences, which will be posted in the investor relations section of the Company's web site at This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:

SOURCE: Impax Laboratories, Inc.

Company Contact:
Impax Laboratories, Inc.
Mark Donohue, Sr. Director Investor Relations
(215) 933-3526